CCM
CELG

Copernicus Capital Management’s Celgene Corp CELG Stock Holding History

Copernicus Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-28,100
Closed -$2.51M – 25
2018
Q1 		$2.51M Buy
+28,100
New +$2.7M 2% 19

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Copernicus Capital Management's CELG Position: Q2 2018 in Review

Copernicus Capital Management sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 28,100 shares — an estimated $2.51M sold.

Copernicus Capital Management first reported a position in CELG in Q1 2018 and held it in 1 quarter. The position peaked at $2.51M in Q1 2018. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Copernicus Capital Management reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Copernicus Capital Management sold 28,100 Celgene Corp shares in Q2 2018, an estimated $2.51M.
  • Copernicus Capital Management first reported a position in Celgene Corp in Q1 2018 and held it in 1 quarter.
  • Copernicus Capital Management's Celgene Corp position peaked at $2.51M in Q1 2018.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Copernicus Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.